Our study performed immunohistochemistry in 190 MTC tissues to evaluate PD-L1 and TIM-3 expression levels in MTC and establish the correlation between their expression and MTC clinicopathological and survival factors. The gene discussed is HAVCR2; the disease is medullary thyroid gland carcinoma.